Khye Seng Goh - Concepedia

Author

Khye Seng Goh

Institut Pasteur de la Guadeloupe

Also Known As

K S Goh, K. S. Goh, K.-S. Goh, K.S Goh, K.S. Goh, Khye S. Goh, Khye Seng Goh

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Institut Pasteur de la Guadeloupe Institut Pasteur Cornell University

About

Khye Seng Goh is an author at Institut Pasteur de la Guadeloupe specializing in microbiology, medicine, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	35	1.8K
2	Health Sciences	17	18	890
3	Natural Sciences	3	3	178
4	Engineering	2	2	108
5	Public Health	1	1	26

Khye Seng Goh

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species A Devallois, Khye Seng Goh, Nalin Rastogi Journal of Clinical Microbiology Pathogenic MicrobiologyGeneticsBacteriologyPhylogenetic AnalysisMicrobial Genetics	1997	242
In Vitro Activities of Fourteen Antimicrobial Agents Against Drug Susceptible and Resistant Clinical Isolates of Mycobacterium tuberculosis and Comparative Intracellular Activities Against the Virulent H37Rv Strain in Human Macrophages Nalin Rastogi, V Labrousse, Khye Seng Goh Current Microbiology Medical MicrobiologyPulmonary TuberculosisHealth SciencesAntibioticsHuman Macrophages	1996	168
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis Nalin Rastogi, Khye Seng Goh, Hugo L. David Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantImmunologyAntimicrobial ChemotherapyM. AviumDrug Resistance	1990	104
Antimycobacterial activity of chemically defined natural substances from the Caribbean flora in Guadeloupe Nalin Rastogi, Jacqueline Abaul, Khye Seng Goh, FEMS Immunology & Medical Microbiology Bioorganic ChemistryAntimicrobial ChemotherapyAntimycobacterial ActivityIndole AlkaloidsDrug Resistance	1998	88
Synergistic activities of antituberculous drugs with cerulenin and<i>trans</i>-cinnamic acid against<i>Mycobacterium tuberculosis</i> Nalin Rastogi, Khye Seng Goh, Lionel Horgen, FEMS Immunology & Medical Microbiology Tuberculosis PreventionAntimicrobial ChemotherapyDrug ResistanceDrug ActivityAntituberculous Drugs	1998	87
Plasmid profiles ofMycobacterium fortuitum complex isolates A Labidi, C. Dauguet, Khye Seng Goh, Current Microbiology Clinical MicrobiologyBacteriologyMicrobiology	1984	64
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis Nalin Rastogi, Khye Seng Goh, A. Bryskier, Antimicrobial Agents and Chemotherapy Mycobacterium Tuberculosis ComplexTuberculosis PreventionAntimicrobial ChemotherapySecond-line Antituberculous DrugsActive L-isomer	1996	64
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages Nalin Rastogi, V Labrousse, Khye Seng Goh, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantAntimicrobial ChemotherapyMbc/mic RatioMycobacterium Avium ComplexDrug Resistance	1991	63
Sequencing of the <i>pncA</i> Gene in Members of the <i>Mycobacterium tuberculosis</i> Complex Has Important Diagnostic Applications: Identification of a Species-Specific <i>pncA</i> Mutation in “ <i>Mycobacterium canettii</i> ” and the Reliable and Rapid Predictor of Pyrazinamide Resistance Ákos Somoskövi, Jillian Dormandy, Linda M. Parsons, Journal of Clinical Microbiology Rapid PredictorPza Susceptibility TestingEngineeringGeneticsTuberculosis Prevention	2006	62
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin Nalin Rastogi, Khye Seng Goh Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyDrug ResistanceMycobacterium TuberculosisInfection ControlHuman Serum	1991	61

Page 1